Hepatic encephalopathy is a liver disease that affects the brain. Learn how a new treatment can treat the disease and prevent ...

Background and aims The performance of neurodegenerative biomarkers-neurofilament light chain (NfL), glial fibrillary acidic protein (GFAP), tau, and ubiquitin carboxy-terminal hydrolase L1 (UCHL1)-in ...

Chronic kidney disease: Late-stage kidney disease prevents these organs from filtering ammonia out of your blood. Hepatic encephalopathy: This condition occurs when a person's liver is too damaged to ...

When these substances enter the brain, they can cause a neurological condition called hepatic encephalopathy. Hepatic encephalopathy typically presents with confusion, lethargy, and sometimes dramatic ...

Neonatal encephalopathy (NE) presents as reduced consciousness, often with seizures, abnormal tone, feeding and respiratory difficulties. The most common cause is secondary to a hypoxic-ischaemic ...

This study shows that the incidence of hepatic encephalopathy was lower in cirrhotic patients with upper gastrointestinal bleed treated with lactulose as compared with patients not treated with ...

Background and Objectives: Developmental and epileptic encephalopathies (DEEs) are a group of neurological disorders characterized by early-onset seizures that are often resistant to treatment, by ...

The clinical presentation of HE varies widely by disease severity and neurocognitive impairment. In MHE, patients might not have obvious clinical changes but instead may have abnormal psychometric ...

Background and Aims: Acute variceal bleed (AVB) is an important precipitating factor for development of hepatic encephalopathy (HE). However, there is paucity of data on the role of lactulose for ...